Genzyme Surgical obtains marketing clearance

GZSP received 510(k) clearance from the FDA to market its Sepramesh prosthetic surgical mesh for use in hernia repair procedures. GZSP was up $1.875 (16 percent) to $13.75 on Wednesday. ...